Evidence map›Paper›PMID 41326937›Full record

ReviewThe protein journal2026

Advantages and Limitations of AlphaFold in Structural Biology: Insights from Recent Studies.

Mandarina Qing Cheng Li, Sihan Wang, Shi-Ruei Lin, Li Eric Ngok Ting, Zhi-Hong Wan, Guodong Xie, Jane Zhang

Abstract readReview
In one paragraph

Review in The protein journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Autophagy modulation in cancer.Nature reviews. Drug discovery · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mandarina Qing Cheng Li *Nanomega CryoAI Corporation, Los Angeles, CA, USA.
Sihan Wang *Nanomega CryoAI Corporation, Los Angeles, CA, USA.
Shi-Ruei Lin *Nanomega CryoAI Corporation, Los Angeles, CA, USA.
Li Eric Ngok TingNanomega CryoAI Corporation, Los Angeles, CA, USA.
Zhi-Hong WanNanomega CryoAI Corporation, Los Angeles, CA, USA.
Guodong XieDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL, USA. guodongxie@uchicago.edu.
Jane ZhangNanomega CryoAI Corporation, Los Angeles, CA, USA. cryoai.nanomega@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past three years, AlphaFold-a deep learning-based protein structure prediction system-has transformed structural biology by providing near-experimental accuracy models directly from amino acid sequences. This narrative review synthesizes applications reported in the 2022-2025 literature across human, microbial, and viral systems, drawing on peer-reviewed studies as our data source. Representative examples include modeling of SARS-CoV-2 spike and nucleocapsid proteins in virology, assisting cryo-EM interpretation of bacterial ribosomal and membrane-protein complexes in microbiology, and refining conformational hypotheses for human GPCRs in biomedicine. Across these cases, AlphaFold predictions have complemented experimental workflows by accelerating hypothesis generation, improving model fitting within ambiguous density regions (poorly resolved areas of cryo-EM maps), and guiding mutagenesis strategies to probe dynamic conformational states. We also summarize recent method extensions: AlphaFold-Multimer improves multi-chain complex assembly prediction, while molecular dynamics (MD) simulations augment AlphaFold's static models by sampling conformational flexibility and testing stability. Despite these advances, important limitations remain-particularly for intrinsically disordered regions, protein-ligand and protein-cofactor interactions, and very large or transient assemblies-and current community benchmarks indicate that approximately one-third of residues may lack atomistic precision, underscoring uncertainty in flexible or modified segments. Framed within a clear chronological window and evidence base, our analysis highlights both the practical impact and the remaining challenges of integrating AlphaFold with experiment, outlining priorities where further methodological innovation and orthogonal validation are needed.

Indexed as

Cryoelectron MicroscopyDeep LearningHumansModels, MolecularMolecular Dynamics SimulationProtein ConformationProtein FoldingSARS-CoV-2AlphaFold/AlphaFold2Cryo-Electron microscopy (cryo-EM)Cryo-Electron tomography (cryo-ET)Integrative structural biologyModel validationProtein–protein interactionsSubtomogram averaging

Identifiers

PMID41326937
PMCPMC12956938

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.